Accumulating preclinical studies show that LRP-1 not only controls how Aβ is metabolized in the brain and peripheral tissues, but also maintains brain homeostasis, which is likely impaired and contributes to AD development in Aβ-independent ways (Shinohara et al., 2017). This evidence concerns the gene LRP1 and Alzheimer disease.